Effects of Active Chronic Cigarette-Smoke Exposure on Circulating Fibrocytes.
Lung
; 202(4): 431-440, 2024 Aug.
Article
in En
| MEDLINE
| ID: mdl-38935158
ABSTRACT
PURPOSE:
This study aimed to evaluate the hypothesis that active smoking impacts upon mediators and abundance of circulating fibrocyte cells in smoking-related disease characterised by fibrosis.METHODS:
Flow cytometry and enzyme-linked immunosorbent assays were used to investigate blood from five patient groups healthy never-smokers, healthy current smokers, stable chronic obstructive pulmonary disease (COPD) active smokers, idiopathic pulmonary fibrosis (IPF) never-smokers, and IPF active smokers.RESULTS:
A significant inverse dose-response relationship was observed in healthy smokers among cumulative smoking burden (pack-years) and fibrocyte abundance (p = 0.006, r = -0.86). Among serum profibrotic fibrocyte chemokines measured, CCL18 rose significantly alongside fibrocyte numbers in all five subject groups, while having an inverse dose-response relationship with pack-year burden in healthy smokers (p = 0.003, r = -0.89). In IPF, CCL2 rose in direct proportion to fibrocyte abundance irrespective of smoking status but had lower serum levels in those currently smoking (p = < 0.001). For the study population, CXCL12 was decreased in pooled current smokers versus never-smokers (p = 0.03).CONCLUSION:
The suppressive effect of current, as distinct from former, chronic smoking on circulating fibrocyte abundance in healthy smokers, and modulation of regulatory chemokine levels by active smoking may have implications for future studies of fibrocytes in smoking-related lung diseases as a potential confounding variable.Key words
Full text:
1
Database:
MEDLINE
Main subject:
Chemokine CCL2
/
Chemokines, CC
/
Pulmonary Disease, Chronic Obstructive
/
Chemokine CXCL12
/
Idiopathic Pulmonary Fibrosis
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2024
Type:
Article